RETIMAGER SEMINAR/WEBINAR “Disruptive Brain PET imager to health market”: a big success !!!

Our RETIMAGER webinar/seminar: “DISRUPTIVE BRAIN PET IMAGER TO HEALTH MARKET” took place on 24 September in “Salón de grados del edificio Padre Soler” of Campus de Leganés, Universidad Carlos III de Madrid with very satisfactory results!

Our Seminar/Webinar had an attendance of over 60 people between presential and online participants, with a very dynamic presentation of the following experts:

  • Rubén Rodríguez, Inspiralia
  • Juan José Vaquero, UC3M
  • José Manuel Udías, UCM
  • David Pérez Beniuto, UC3M
  • Egan Balaban, UC3M-NSF
  • David Izquierdo, UC3M – Havard-MIT
  • Carlos Díaz, Synapse

plus the additional indirect collaboration of all the rest of the partners for different preparations.

A survey was sent after the meeting to all participants, where we had the opportunity to get these extremely useful pieces of information that will be really valuable for us to better know how to orientate our roadmap. The following images detail the feedback received:

Besides these answers, we received general comments which also resulted both very useful and extremely encouraging for us to continue doing our best to make RETIMAGER a real product in the market:

“I found really interesting the reflexive talk of Carlos Díaz, I think it was a good idea to bring him to express some of the drawbacks in this kind of business”, representing the importance to consider the Industry as crucial stakeholders in our strategies.

“I found fascinating to observe the whole process of developing a new technology […] from the physics, need, design process, economy, possible consequences. […] It showed all the actors at play, the need of finding, etc.”, clearly stating the need to combine different activities of different nature to achieve the desired final scientific, technical medical and socio-economic impact.

The gallery below shows the different participation of all the experts and the great expectation created around our Seminar/Webinar.